M&A Deal Summary |
|
|---|---|
| Date | 2019-07-01 |
| Target | Studiekring |
| Sector | Education |
| Buyer(s) | Lyceo |
| Sellers(s) | GIMV |
| Deal Type | Add-on Acquisition |
SEARCH BY
Lyceo offers many different forms of educational support: from homework guidance, tutoring and exam training to study choice and learning to code. Lyceo was founded in 2008 and is based in Leiden, Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Education M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Netherlands M&A | 1 of 1 |
| Year: 2019 M&A | 1 of 1 |
| Category | Private Equity Firm |
|---|---|
| Founded | 1980 |
| PE ASSETS | 2.0B EUR |
| Size | Large |
| Type | Sector Agnostic |
GIMV is a Belgium based public investment company focused on private equity and venture capital investments in tech-based businesses. GIMV's private equity practice operates through its Corporate Investment unit and targets management buyouts, buy-ins, and growth capital financings of companies with annual sales between EUR15 and EUR150 million. For buyout opportunities GIMV generally takes a majority stake in businesses and for growth capital needs, GIMV takes a minority position. GIMV does not invest in publicly held companies or turnaround situations. GIMV's geographic focus is within Belgium, Netherlands, Germany, and France. GIMV also invests in Russia through Eagle Capital Partners, a partnership with KBC Private Equity. GIMV was formed in 1980 and is headquartered in Antwerp with additional offices in The Hague, Frankfurt, Munich, and Paris.
| DEAL STATS | # |
|---|---|
| Overall | 85 of 111 |
| Sector: Education M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 46 of 58 |
| Country: Netherlands M&A | 23 of 29 |
| Year: 2019 M&A | 2 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-06-18 |
Alro Group
Dilsen-Stokkem, Belgium Alro Group provides an industrial coating of car and truck parts. Alro Group was founded in 1976 and is based in Dilsen-Stokkem, Belgium. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-07-25 |
Breath Therapeutics
Munich, Germany Breath Therapeutics is a clinical stage biopharmaceutical company specializing in advanced inhaled therapeutics for severe respiratory diseases with a high unmet medical need. |
Sell | €140M |